Skip to main content
. 2023 Nov 16;21:819. doi: 10.1186/s12967-023-04703-5

Table 2.

The relationship between PTPRH expression and clinical characteristics of NSCLC patients

Clinical characteristics N PTPRH expression level (mean ± standard deviation) P value
Age (year) 0.320
 ≥ 60 41 6.64 ± 2.867
 < 60 39 7.27 ± 2.737
Gender 0.670
male 45 6.83 ± 2.828
female 35 7.20 ± 2.807
Tumor diameter (cm) 0.004**
 ≤ 3 54 6.21 ± 2.274
 > 3 26 7.94 ± 2.7363
Clinical stage 0.003**
 I–II 43 5.28 ± 2.1310
 III–IV 37 6.97 ± 2.8042